论文部分内容阅读
上海医药(集团)有限公司(以下简称:集团)为了加快上海生物医药和现代中药产业的发展,进一步提高集团持续赢利增长,建设符合GMP(药品生产质量管理基本规范)、GSP(药品经营管理基本规范)要求的现代医药企业,集团进行了一系列的三废迁建技改项目、GMP改造项目等投资建设。投资规模从几百万、几千万到上亿不等,近二年的《中药复方提取物先进生产工艺高技术产业化示范工程》、《医药连锁及现代
In order to speed up the development of Shanghai Biomedicine and modern Chinese medicine industry, Shanghai Pharmaceutical (Group) Co., Ltd. further enhanced the Group’s profitability and continued to grow. The Group met the requirements of GMP (Basic Specification for Pharmaceutical Production Quality Management), GSP Standard) requirements of the modern pharmaceutical companies, the Group conducted a series of waste removal and relocation of technological transformation projects, GMP reconstruction projects such as investment and construction. Investment scale from millions, tens of millions to billions of dollars, nearly two years of “Chinese herbal extract advanced production technology of high-tech industrialization demonstration project”, "pharmaceutical chain and modern